The Food and Drug Administration (FDA) has approved Moderna’s next-generation mRNA COVID-19 vaccine mNexspike ®.

(HealthDay News) — The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.

Agency’s new road map aims for faster approvals and healthier food, but some experts caution AI is not yet up to the task.

With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed ...

The Trump administration has declared an end to COVID-19 vaccine recommendations for children and pregnant people, and health ...

Under the new guidance, children 6 months and older may receive COVID-19 vaccinations, if parents’ decisions are “informed by ...

U.S. public health authorities have skirted normal procedures and announced two major policy changes that will likely reduce ...

Novavax, Inc. (NVAX) on Wednesday said that its COVID-19-Influenza combination and stand-alone Influenza vaccine candidates ...

NB.1.8.1 has mutations that could increase the virus’s transmissibility and decrease the efficacy of certain neutralizing ...

The HHS document also includes an incorrect link for that study, instead leading to a different study — also cited in HHS’ document — by Israeli researchers that found the vaccine “appears to be safe ...

A vaccine expert assured Filipinos on Wednesday that all vaccines are safe after the United States Food and Drug ...